The evaluation of Hepatitis C virus core antigen in immunized Balb/C mice

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: Hepatitis infection represents one of the important causes of morbidity and mortality in developing countries, however there is not any effective vaccine against hepatitis C which is one of the significant problems in vaccine project. Material and Methods: Our previous cloned plasmid (HCV Core gene into pETDuet-1) applied for protein expression in bacteria. The expressed and purified recombinant protein together with Freund's adjuvant was injected to 15 Balb/c mice. The total IgG and IgG2a of immunized mice sera were evaluated after a week. Two weeks after booster injection, we studied the proliferation and IFNγ secretion of spleens, inguinal and popliteal lymph nodes lymphocytes by ELISA and ELISPOT. Results: The FSFC (Frequency of spot forming cells) of secreting cells of immunized mice with HCV/Core protein and sera IgG2a were considerably higher than the control groups. Conclusion: The core protein together with proper adjuvant can be a candidate vaccine against of HCV infection. © 2012 Kowsar Corp. All rights reserved.

Cite

CITATION STYLE

APA

Torbati, E., Bandehpour, M., Pakzad, P., Mosaffa, N., & Kazemi, B. (2012). The evaluation of Hepatitis C virus core antigen in immunized Balb/C mice. Hepatitis Monthly, 12(6), 71–77. https://doi.org/10.5812/hepatmon.6141

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free